Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 70 Breast Neoplasms 64 Neoplasms 35 Carcinoma, Non-Small-Cell Lung 29 Neoplasm Metastasis 20 Triple Negative Breast Neoplasms 18 Lung Neoplasms 13 Ovarian Neoplasms 12 Adenocarcinoma 12 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 10 Head and Neck Neoplasms 8 Fallopian Tube Neoplasms 7 Cholangiocarcinoma 7 Urinary Bladder Neoplasms 6 Recurrence 6 Esophageal Neoplasms 6 Digestive System Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Uterine Cervical Neoplasms 4 Sarcoma, Ewing 4 Sarcoma 4 Prostatic Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Pancreatic Diseases 4 Inflammatory Breast Neoplasms 4 Gallbladder Neoplasms 4 Endocrine Gland Neoplasms 4

Interventions

Gemcitabine 2 selicrelumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma Pancreas × Albumin-Bound Paclitaxel × Clear all

NCT02812992 2021-08-10

GrantPax

AIO-Studien-gGmbH

Phase 4 Completed

Gastrointestinal

Adenocarcinoma Pancreas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡